Global Med Technologies(R), Inc. Announces Prestigious New Client for Donor and Transfusion Software Installation Both SafeTrace(R) and SafeTrace Tx(R) Selected DENVER, July 7 /PRNewswire-FirstCall/ -- Mayo Clinic, one of the most prestigious medical centers in the world, has purchased SafeTrace(R) and SafeTrace Tx(R)* from Global Med Technologies, Inc.'s Wyndgate Technologies(R) division to provide donor and hospital transfusion software at its Rochester, Minnesota location. Terms were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Dr. Mick Ruxin, Chairman and CEO of Global Med Technologies, Inc., stated, "We, at Global Med, are very excited to be working with Mayo Clinic. Wyndgate aspires to support Mayo Clinic's purchase with its quality of people, reputation for service, commitment to excellence, and high standards for technological superiority in the industry." Dr. Ruxin added, "We believe this very significant business agreement with Mayo Clinic underscores our commitment to quality and safety in helping healthcare facilities of all sizes and levels of complexity to manage the Vein-to-Vein(R) cycle from collection to transfusion." About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace donor management system provide Vein-to-Vein tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. Statements in this press release that are not strictly historical are "forward-looking" statements within the meaning of the Safe Harbor provisions of the federal securities laws. Forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the Company's products and services in the marketplace, regulatory and competitive factors, new products and technological changes, the Company's dependence upon third-party suppliers, and other risks detailed from time to time in the Company's Form 10-K and other regularly filed reports. *Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Press, Patti Larson, Senior Director of Marketing Development, +1-916-404-8492, , or Investors, Tom Marcinek, President and COO, +1-916-404-8413, , both of Global Med Technologies, Inc. Web site: http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web site: http://www.globalmedtech.com/

Copyright